Skinvisible, Inc.

SKVI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $629.0K $108.9K $174.6K $54.9K $66.7K $270.3K $180.2K $229.2K
Cost of Revenue $42.3K $37.1K $56.9K $26.5K $2.2K $4.6K $1.7K $19.5K
Gross Profit $586.7K $71.8K $117.7K $28.4K $64.5K $265.7K $178.5K $209.7K
Gross Margin 93.3% 66.0% 67.4% 51.8% 96.7% 98.3% 99.1% 91.5%
Operating Expenses
Research & Development
SG&A Expense $896.5K $855.9K $1.1M $1.2M $786.9K $1.5M $1.4M $968.0K
Operating Income $-364.2K $-841.7K $-1.1M $-1.2M $-759.5K $-1.3M $-1.2M $-800.2K
Operating Margin -57.9% -773.0% -618.7% -2,123.4% -1,138.8% -489.8% -681.6% -349.2%
Interest Expense $1.6M $1.3M $915.2K $755.5K $-588.1K $-173.8K $-127.2K $-272.8K
Pretax Income
Income Tax Expense
Net Income $-1.8M $-2.1M $-2.0M $-1.9M $-1.3M $-1.5M $-1.4M $-1.1M
Net Margin -290.4% -1,883.4% -1,139.6% -3,507.3% -2,014.3% -537.3% -755.0% -468.2%
EPS (Basic) $-0.06 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
EPS (Diluted)
Shares Outstanding (Basic) 31.2M 1.42B 1.37B 1.34B 1.33B 1.30B 1.22B 1.08B
Shares Outstanding (Diluted) 31.2M 1.42B 1.37B 1.34B 1.33B 1.30B 1.22B 1.08B
Dividends Per Share
← Newer Page 2 of 2 Older →